In turn, tumor cells from the only chondrosarcoma (CDS) analyzed were also positive for GD2 and CD9, in addition to CD81 and CD90, and they lacked CD10, CD58, nuMyoD1, numyogenin, CD57, and CD99 expression (Figure 3 and Table 2). This evidence concerns the gene CD58 and chondrosarcoma.